CONSONANCE CAPITAL MANAGEMENT LP

Company

Aptose Biosciences Inc.

Filed

February 14, 2020

Accession Number

0001085146-20-000753

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →